Medication info
Mesar 20 mg (Olmesartan Medoxomil)

Mesar 20 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Hawon Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100945 · Approved 2011.02.25 · Insurance code 651503280

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect reached after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), treatment should preferably be initiated at a low dose, with their condition monitored closely. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Hawon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is used to control blood pressure within normal ranges to protect heart and vascular health.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect reached after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), treatment should preferably be initiated at a low dose, with their condition monitored closely. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any ingredients in this medication, those who are pregnant or breastfeeding, patients on kidney dialysis, severely impaired liver function patients, patients with bile duct obstruction, and those with lactose intolerance should not take this medication. Patients with low blood volume or sodium may experience hypotension, so their condition should be carefully checked before administration and monitored closely after. Severe heart failure or patients with kidney function issues may experience worsening kidney function, so frequent blood tests to monitor kidney status are necessary. This medication may cause hyperkalemia, so patients with heart disease or kidney disease should closely monitor their serum potassium levels. Dizziness may occur, so it is advisable to avoid driving or operating hazardous machinery. The blood pressure-lowering effect may be enhanced if this medication is taken with other antihypertensive drugs; thus, it is crucial to inform your healthcare provider of any other medications you are taking. Caution is necessary when taken with potassium-sparing diuretics or potassium supplements, as blood potassium levels may become dangerously high. When taken with lithium, it may increase lithium levels and cause toxicity, so co-administration is not advisable. Taking non-steroidal anti-inflammatory drugs (NSAIDs) with this medication can worsen kidney function, requiring adequate hydration and kidney function monitoring. Taking this medication during pregnancy can have fatal consequences for the fetus; therefore, if you are planning to become pregnant or are pregnant, consult your doctor. If breastfeeding, this medication may be transferred to breast milk, putting the infant at risk for adverse reactions, so it may be necessary to discontinue breastfeeding or stop taking this medication. Safety for pediatric patients has not been established, so it is preferable for children not to use this medication. Older adults may experience increased drug concentration, and caution is advised when administering this medication. In cases of overdose, symptoms such as hypotension and palpitations may occur; any symptoms should be reported to healthcare professionals immediately, and appropriate treatment is required. Although no carcinogenic risk has been reported with long-term use of this medication, rare side effects such as liver function abnormalities, skin rashes, and angioedema may occur; consult healthcare professionals immediately if any unusual symptoms arise.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 41 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma
  • positional vertigo
  • palpitations
  • epistaxis
  • upper respiratory infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store the medication at room temperature, between 1 and 25 degrees Celsius, to maintain its efficacy.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.